| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.29 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |